FilingsAtlas Logo - Company Search & Market Tools
FilingsAtlas

SeaStar Medical Holding Corp (ICU) Financial Statements

Industry: Surgical & Medical Instruments & Apparatus

In fiscal 2025, SeaStar Medical reported revenue of $1.2M, up 814.1% from $135,000 the year before. Net income was -$12.2M (a -984.6% net margin). Gross margin was 95.7% and operating margin was -986.6%. Operating activities generated -$13.6M of cash. At fiscal year end, SeaStar Medical held $14.2M in total assets against $3.7M in total liabilities.

Open the full interactive SeaStar Medical financials → Quarterly statements, key ratios, valuation history and price charts.

SeaStar Medical Key Stats

Share Price$3.59
Market Cap$14.7M
Revenue YoY Growth+814.1%
52-Week Range$2.21 – $6.37
Shares Outstanding4.1 million (basic, 2026 Q2)

SeaStar Medical Income Statement

SeaStar Medical Holding Corp annual income statement
FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$0$0$0$135,000$1.2M
Cost of Goods Sold———$0$53,000
Gross Profit———$135,000$1.2M
Operating Income-$1.1M-$11.6M-$14.2M-$17.8M-$12.2M
Pre-Tax Income$75,317-$23.0M-$26.2M-$24.8M-$12.1M
Income Tax—$1,000$0$3,000$3,000
Net Income$75,317-$23.0M-$26.2M-$24.8M-$12.2M
Diluted EPS$1.95-$700.00-$302.50-$66.30—

SeaStar Medical Quarterly Results

SeaStar Medical Holding Corp last 4 quarters
2025 Q32025 Q42026 Q12026 Q2
Revenue$183,000$420,000$495,000$615,000
Net Income-$3.5M-$2.9M-$3.5M-$3.7M

SeaStar Medical Balance Sheet

SeaStar Medical Holding Corp annual balance sheet (fiscal year end)
FY 2021FY 2022FY 2023FY 2024FY 2025
Cash & Equivalents$51,567————
Current Assets—$3.0M$2.3M$3.8M$13.6M
Total Assets$105.9M$4.8M$3.5M$4.7M$14.2M
Current Liabilities$376,702$5.3M$13.0M$6.8M$3.7M
Total Long-Term Debt—$8.8M$4.1M$1.1M—
Total Liabilities$10.9M$13.0M$17.4M$6.8M$3.7M
Shareholders' Equity-$10.6M-$8.2M-$13.9M-$2.2M$10.4M

SeaStar Medical Cash Flow Statement

SeaStar Medical Holding Corp annual cash flow statement
FY 2021FY 2022FY 2023FY 2024FY 2025
Cash From Operations-$1.2M-$7.8M-$10.3M-$16.0M-$13.6M
Cash From Investing-$105.6M————
Cash From Financing$106.8M$7.3M$10.4M$17.6M$23.8M

Figures from SeaStar Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full SeaStar Medical financials page for every line item.

SeaStar Medical Company Profile

TickerICU
ExchangeNasdaq
IndustrySurgical & Medical Instruments & Apparatus
HeadquartersDenver, Colorado
Incorporated inColorado
Fiscal Year EndDecember 31
SEC Filer CategoryEmerging growth company
SEC CIK0001831868

Frequently Asked Questions

What was SeaStar Medical's revenue in fiscal 2025?

SeaStar Medical (ICU) reported revenue of $1.2M for fiscal 2025.

What is SeaStar Medical's annual revenue history?

SeaStar Medical's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $135,000; 2025: $1.2M.

What was SeaStar Medical's net income in fiscal 2025?

SeaStar Medical reported net income of -$12.2M for fiscal 2025.

What was SeaStar Medical's revenue last quarter?

In its most recent reported quarter (2026 Q2), SeaStar Medical reported revenue of $615,000.

How many shares of SeaStar Medical are outstanding?

SeaStar Medical reported a weighted average of 4.1 million basic shares outstanding in 2026 Q2.

What is SeaStar Medical's market cap?

Based on its latest closing price, SeaStar Medical (ICU) has a market capitalization of about $14.7M.

When does SeaStar Medical's fiscal year end?

SeaStar Medical's fiscal year end, as registered with the SEC, is December 31.

Where is SeaStar Medical headquartered?

SeaStar Medical lists its business address in Denver, Colorado in its SEC filings.